The forecasted mortality for malignant neoplasms of the colon, rectum, and anus in US males shows a slight year-on-year increase from 2024 to 2028, with values rising from 28.85 thousand in 2024 to 29.24 thousand in 2028. Compared to the actual value of 28.75 thousand in 2023, the year-on-year variations reflect incremental growth: 0.35% from 2024 to 2025, 0.35% from 2025 to 2026, 0.34% from 2026 to 2027, and 0.31% for 2027 to 2028. The compound annual growth rate (CAGR) indicates a steady rise in mortality by approximately 0.35% annually over this forecast period.
Future trends to watch for include advancements in early detection and treatment methods, the impact of healthcare policies, and shifts in demographic factors such as aging populations. Additionally, understanding the influence of lifestyle changes and preventive measures could provide nuanced insights into mortality trends.
